One Drop Launches Global Commercial Partnership with Bayer

Vinson & Elkins advised One Drop, a leader in the development of digital therapeutic solutions for diabetes and other chronic conditions, in connection with a $40 million Series B financing, led by Bayer, one of the largest pharmaceutical companies in the world.

Bayer has also entered a commercial licensing agreement to use One Drop’s platform in Bayer’s global bio-digital efforts in therapeutic areas such as oncology, cardiovascular disease and women’s health.

The V&E corporate team was led by partner Paul Tobias and counsel Andy Smetana with assistance from associates Ben Cukerbaum and Vaughn Miller. Also advising was partner Damara Chambers.

About Vinson & Elkins
For more than 100 years, Vinson & Elkins has provided deep experience in handling transactions, investments, projects, and disputes worldwide. The firm is a trusted adviser to clients in the most important industrial and digital industries. Learn more by visiting www.velaw.com or follow us on Twitter @VinsonandElkins or connect with us on LinkedIn.

For more information, please speak with our media contacts.

One Drop Launches Global Commercial Partnership with Bayer

Related Insights